Overview

SB208 for the Treatment of Tinea Pedis

Status:
Completed

Trial end date:
2017-02-01

Target enrollment:

Participant gender:

Summary

This is a phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted in non immunocompromised adult subjects with interdigital tinea pedis.

Phase:

Phase 2

Details

Lead Sponsor:

Novan, Inc.